A
AMR Conventions Research | Warrenville, IL
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
SEP-4199
SEP-363856
Oral Icalcaprant
Oral
Icalcaprant
Vortioxetine
Fluoxetine
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 6 total trials
Bipolar disorder is a severe chronic mood disorder that affects up to 4% of the adult population and 1.8% of the pediatric population in the United S...
Enrolling
Bipolar II Disorder
Bipolar I Disorder
Drug: Icalcaprant
Drug: Placebo for Icalcaprant
Major depressive disorder (MDD; depression) is a mood disorder that causes a continued feeling of sadness and loss of interest. It is a common and se...
Enrolling
Major Depressive Disorder
Drug: Icalcaprant
Drug: Placebo for Icalcaprant
Locations recently updated
This is a global, phase 3, randomized, double-blind, parallel-group, 3-arm, placebo-controlled, multicenter study designed to compare the efficacy, s...
Enrolling
Generalized Anxiety Disorder
Drug: SEP-363856
Other: Placebo
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems